Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
Medical Oncology
Published in: Medical Oncology 1/2011

01-12-2011

Activity of trabectidin in desmoplastic small round cell tumor

Published in: Medical Oncology | Special Issue 1/2011

Login to get access

Abstract

Desmoplastic small round cell tumor (DSRCT) is a rare and aggressive cancer that typically arises in teenage boys. As a result of its low prevalence, there have been few studies of its treatment and impact on survival. Here, we report the case of a patient who was refractory to multiple drugs but remains stable with trabectedin. To our knowledge, this is the first published report that supports antitumoral activity of trabectedin in DSRCT.
Literature
1.
Stuart-Buttle CE, Smart CJ, Pritchard S, Martin D, Welch IM. Desmoplastic small round cell tumour: a review of literature and treatment options. Surg Oncol. 2008;17(2):107–12.PubMedCrossRef
2.
Tejerina González E, Corbacho Cuevas C, López García A, Bellas C, Sánchez V, Sánchez Ruiz A, de Álava E, Sanz E. Tumor intraabdominal desmoplásico de células pequeñas y redondas. Revisión de la literatura a propósito de un caso con estudio citológico, histopatológico, inmunohistoquímico y molecular. Oncología. 2007;30(1):25–31.
3.
Landayi M, Gerald W. Fusion of the EWS and WT1 genes in the desmoplastic small round cell tumors. Cancer Res. 1994;54:2837–40.
4.
Hassan I, et al. Intraabdominal desmoplastic small round cell tumours—a diagnostic and therapeutic challenge. Cancer. 2005;104(6):1264–70.PubMedCrossRef
5.
Livaditi E, Mavridis G, Soutis M, et al. Diffuse intraabdominal desmoplastic small round cell tumour: a ten-year experience. Eur J Pediatr Surg. 2006;16(6):423–7.PubMedCrossRef
6.
Herrero AB, Martín-Castellanos C, Marco E, Gago F, Moreno S. Cross-talk between nucleotide excision and homologous recombination DNA repair pathways in the mechanism of action of antitumor trabectedin. Cancer Res. 2006;66(16):8155–62.PubMedCrossRef
7.
Grosso F, et al. Efficacy of trabectedin (ecteinascidin-743) in advanced pretreated myxoid liposarcomas: a retrospective study. Lancet Oncol. 2007;8:595–602.PubMedCrossRef
8.
Grosso F, et al. Trabectedin in myxoid liposarcomas (MLS): a long-term analysis of a single-institution series. Ann Oncol. 2009;20(8):1439–44.PubMedCrossRef
9.
Bonfanti M, La Valle E, Fernández Sousa-Faro JM, Faircloth G, Caretti G, Mantonvani R, D’Incalci M. Effect of ecteinascidin-743 on the interaction between DNA binding proteins and DNA. Anticancer Drug Des. 1999;14:179–86.PubMed
10.
Forni C, et al. Trabectedin (ET-743) promotes differentiation in myxoid liposarcoma tumors. Mol Cancer Ther. 2009;8(2):449–57.PubMedCrossRef
11.
Tavecchio M, et al. Dynamics of cell cycle phase perturbations by trabectedin (ET-743) in nucleotide excision repair (NER)-deficient and NER-proficient cells, unravelled by a novel mathematical simulation approach. Cell Prolif. 2007;40:885–904.PubMedCrossRef
12.
Tavecchio M, et al. Role of homologous recombination in trabectedin-induced DNA damage. Eur J Cancer. 2008;44:609–18.PubMedCrossRef
13.
Soares DG, et al. Replication and homologous recombination repair regulate DNA double-strand break formation by the antitumor alkylator ecteinascidin 743. PNAS. 2007;104(32):13062–7.PubMedCrossRef
Metadata
Title
Activity of trabectidin in desmoplastic small round cell tumor
Publication date
01-12-2011
Published in
Medical Oncology / Issue Special Issue 1/2011
Print ISSN: 1357-0560
Electronic ISSN: 1559-131X
DOI
https://doi.org/10.1007/s12032-010-9687-9

Other articles of this Special Issue 1/2011

Medical Oncology 1/2011 Go to the issue

Original paper

A phase II randomized study comparing navelbine and capecitabine (Navcap) followed either by Navcap or by weekly docetaxel in the first-line treatment of HER-2/neu negative metastatic breast cancer

Review Article

Lymphoma of the breast in a male patient

Original paper

Predictors of mammography use in older women with disability: the patients’ perspectives

Original Paper

Clear cell odontogenic carcinoma: report of 6 cases and review of the literature

Orginal Paper

Significance of survivin and Bcl-2 homologous antagonist/killer mRNA in detection of bone metastasis in patients with breast cancer

Original Paper

Long-term survey of outcome in acute promyelocytic leukemia: a single center experience in 340 patients

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits